These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4945580)

  • 61. Trends in antimicrobial susceptibility of Escherichia coli isolates from urology services in The Netherlands (1998-2005).
    Nys S; Terporten PH; Hoogkamp-Korstanje JA; Stobberingh EE;
    J Antimicrob Chemother; 2008 Jul; 62(1):126-32. PubMed ID: 18417487
    [TBL] [Abstract][Full Text] [Related]  

  • 62. In vitro activity of prulifloxacin against Escherichia coli isolated from urinary tract infections and the biological cost of prulifloxacin resistance.
    Gualco L; Schito AM; Schito GC; Marchese A
    Int J Antimicrob Agents; 2007 Jun; 29(6):679-87. PubMed ID: 17363225
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Synergistic bactericidal effect of cephalexin and normal cord serum (NCS) against Escherichia coli K1 strains isolated from children with urinary tract infections (UTI).
    Cisowska A; Jankowski S; Doroszkiewicz W
    Acta Microbiol Pol; 1999; 48(4):381-3. PubMed ID: 10756721
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparative antimicrobial resistance and genomic diversity of Escherichia coli isolated from urinary tract infections in the community and in hospitals.
    Perrin M; Donnio PY; Heurtin-Lecorre C; Travert MF; Avril JL
    J Hosp Infect; 1999 Apr; 41(4):273-9. PubMed ID: 10392333
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anti-microbial resistance stratified by risk factor among Escherichia coli strains isolated from the urinary tract at a rural clinic in Central India.
    Chatterjee B; Kulathinal S; Bhargava A; Jain Y; Kataria R
    Indian J Med Microbiol; 2009; 27(4):329-34. PubMed ID: 19736402
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Chloramphenicol- and tetracycline-resistant uropathogenic Escherichia coli (UPEC) exhibit reduced virulence potential.
    Starcic Erjavec M; Rijavec M; Krizan-Hergouth V; Fruth A; Zgur-Bertok D
    Int J Antimicrob Agents; 2007 Nov; 30(5):436-42. PubMed ID: 17719751
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Analysis of anti-microbial resistance of Escherichia coli that caused infection in urogenital system].
    Cui WL; Xu DX; Li WL; Wang LX
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Aug; 24(8):940-2, 945. PubMed ID: 15321769
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Resistance of uropathogens in symptomatic urinary tract infections in León, Nicaragua.
    Matute AJ; Hak E; Schurink CA; McArthur A; Alonso E; Paniagua M; Van Asbeck E; Roskott AM; Froeling F; Rozenberg-Arska M; Hoepelman IM
    Int J Antimicrob Agents; 2004 May; 23(5):506-9. PubMed ID: 15120732
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2.
    Stratchounski LS; Rafalski VV
    Int J Antimicrob Agents; 2006 Aug; 28 Suppl 1():S4-9. PubMed ID: 16829055
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Clinical importance of the antibiogram in nonspecific chronic urinary tract infections].
    Zischka-Konorsa W; Hermanek P; Haschek H; Bibus B; Porpaczy P
    Wien Med Wochenschr; 1967 Nov; 117(47):1073-80. PubMed ID: 5595848
    [No Abstract]   [Full Text] [Related]  

  • 71. [Profile of antimicrobial resistance of agents causing urinary tract infections in children].
    Ghedira Besbes L; Messaoudi A; Ben Meriem C; Guediche MN
    Tunis Med; 2004 Mar; 82(3):299-305. PubMed ID: 15382465
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Prevalence of virulence factors and antimicrobial resistance of uropathogenic Escherichia coli in Jiangsu province (China).
    Zhao L; Chen X; Zhu X; Yang W; Dong L; Xu X; Gao S; Liu X
    Urology; 2009 Sep; 74(3):702-7. PubMed ID: 19362346
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Antibiotic resistance in bacterial urinary tract infections, 1991 to 1997.
    Dyer IE; Sankary TM; Dawson JA
    West J Med; 1998 Nov; 169(5):265-8. PubMed ID: 9830353
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
    Akyar I
    Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients.
    Urbánek K; Kolár M; Strojil J; Koukalová D; Cekanová L; Hejnar P
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):741-5. PubMed ID: 15880441
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Changes of antimicrobial resistance among clinical isolates of Escherichia coil in Shanghai 1990-2004].
    Zhang YY; Zhu DM; Hu FP; Wu S; Wang F
    Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(1):12-6. PubMed ID: 16606528
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Urinary tract infections in outpatients treated in 2002-2003].
    Luczak M; Rokosz A; Wachnik A; Kamola R; Stypułkowska A
    Przegl Lek; 2005; 62(2):81-5. PubMed ID: 16095149
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Non-hospital antimicrobial usage and resistance in community-acquired Escherichia coli urinary tract infection.
    Kahlmeter G; Menday P; Cars O
    J Antimicrob Chemother; 2003 Dec; 52(6):1005-10. PubMed ID: 14613955
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Dissemination of clonal groups of uropathogenic Escherichia coli is not a significant contributor to trimethoprim and sulfamethoxazole resistance in Galway, Ireland.
    Morris D; Ni Chulain M; Cormican M
    Int J Antimicrob Agents; 2007 Jul; 30(1):97-8. PubMed ID: 17459666
    [No Abstract]   [Full Text] [Related]  

  • 80. [Preventive effect of combinations of native antibiotics in experimental gas infection].
    Chirkin IuD
    Antibiotiki; 1970 Feb; 15(2):126-8. PubMed ID: 4910123
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.